Thanks to advances in medical care, nutrition and public health policy, people around the world are living longer — but also coping with more illness as they age. Researchers at the Purdue Institute for Drug Discovery are focused on slowing that trend by developing new diagnostic tools and treatments for people in need. We will accelerate the rate of drug discovery to move revelations from the lab to commercialization and then to the millions of patients who need hope and relief.
- Accelerate the rate of drug discovery to move revelations from the lab to commercialization and then to the millions of patients who need hope and relief.
- Create an innovative research and teaching environment to stimulate discovery and the translation of basic research into new ways to diagnose and treat disease.
- Increase grant funding and industry investment.
- Attract new researchers of international reputation and proven ability.
- Foster research, clinical translation, education and commercialization in the development of lifesaving and life-enhancing drugs.
- The Purdue Institute for Drug Discovery was established in 2013 as part of Purdue's Discovery Park, with the mission of developing new diagnostic tools and treatments for people in need.
- With over 120 researchers from various disciplines, our scientists bring a rich diversity of experience to pharmaceutical discovery.
- Purdue researchers have advanced 24 new drugs into human trials, plus 73 more in the pipeline.
- Researchers at the Institute for Drug Discovery were issued their 300th patent in 2020.
- In 2019, the Alzheimer's Disease Drug Discovery Center, supported by a $36 million grant from the National Institute on Aging, was created within the Institute for Drug Discovery and in partnership with the Indiana University School of Medicine.
- A new Drug Discovery Training Program, supported by the NIH, began in 2019 that supports unique and exclusive opportunities for select graduate students to better educate the next generataion of drug discovery and development scientists.
- Since the founding of the Purdue Institute for Drug Discovery, affiliated faculty have:
- Initiated more than 25 human clinical trials to test Purdue discovered drugs
- Tripled the number of faculty contributing to Purdue’s drug pipeline
- Published 3,600+ scholarly articles
- Tripled the average number of manuscripts accepted by high impact journals
- Filed more than 425 U.S. patents
- Been issued 330 U.S. patents,
- Raised roughly $525 million in total funding
- Generated over 1,800 collaborative works (i.e. publications, grants, and patents), and
- Founded 38 startup companies which together have raised more than $200 million in venture capital and $2 billion from acquisitions.
- In an effort to expand the impact of Purdue's prominence in drug discovery worldwide, the university has cultivated partnerships with non-profit companies and foundations, research institutions, medical centers, and pharmaceutical companies on projects where our individual strengths can synergize to more rapidly discover/develop new drugs and advance these drugs into the clinic.
- Purdue-discovered or developed drugs have been tested in 334 clinical trials at 5224 sites with more than 150,000 participants world-wide.
- Purdue has numerous drugs in the pipeline undergoing clinical trials.
- The Purdue Institute for Drug Discovery has built state-of-the-art facilities that promote the discovery, design and development of new drugs through innovative architecture that encourages collaborations in chemistry, medicinal chemistry and biology.
- Purdue's drug discovery researchers have made many promising advances in drug discoverysince the Purdue Moves were announced.